Renaissance Technologies
KRYS icon

Renaissance Technologies’s Krystal Biotech KRYS Stock Holding History

Renaissance Technologies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.2M Buy
59,680
+50,080
+522% +$15M 0.03% 657
2026
Q1 		$2.48M Buy
9,600
+6,300
+191% +$1.68M ﹤0.01% 1779
2025
Q4 		$814K Buy
+3,300
New +$695K ﹤0.01% 2377
2025
Q3 		– Sell
-89,800
Closed -$12.3M – 3727
2025
Q2 		$12.3M Buy
89,800
+78,600
+702% +$11.5M 0.02% 944
2025
Q1 		$2.02M Buy
11,200
+300
+3% +$50.5K ﹤0.01% 1999
2024
Q4 		$1.71M Sell
10,900
-3,500
-24% -$621K ﹤0.01% 2154
2024
Q3 		$2.62M Buy
+14,400
New +$2.78M ﹤0.01% 1845
2024
Q2 		– Sell
-24,700
Closed -$4.39M – 3763
2024
Q1 		$4.39M Buy
+24,700
New +$3.43M 0.01% 1497
2021
Q4 		– Sell
-33,300
Closed -$1.74M – 4085
2021
Q3 		$1.74M Buy
+33,300
New +$1.97M ﹤0.01% 2198
2020
Q4 		– Sell
-19,600
Closed -$844K – 3567
2020
Q3 		$844K Sell
19,600
-41,800
-68% -$1.82M ﹤0.01% 2596
2020
Q2 		$2.54M Buy
61,400
+55,400
+923% +$2.67M ﹤0.01% 2043
2020
Q1 		$259K Buy
+6,000
New +$314K ﹤0.01% 3025
2019
Q2 		– Sell
-30,800
Closed -$1.01M – 3661
2019
Q1 		$1.01M Sell
30,800
-11,100
-26% -$262K ﹤0.01% 2664
2018
Q4 		$871K Sell
41,900
-8,800
-17% -$184K ﹤0.01% 2643
2018
Q3 		$891K Buy
+50,700
New +$851K ﹤0.01% 2649

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies's KRYS Position: Q2 2026 in Review

Renaissance Technologies increased its Krystal Biotech (KRYS) stake by 522% in Q2 2026, buying an estimated $15M and bringing the position to 59,680 shares worth $22.2M. The position accounts for 0.03% of the portfolio, ranked #657.

Renaissance Technologies first reported a position in KRYS in Q3 2018 and has held it in 15 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Renaissance Technologies held 59,680 shares of Krystal Biotech worth $22.2M as of Q2 2026.
  • Renaissance Technologies bought 50,080 Krystal Biotech shares in Q2 2026, an estimated $15M.
  • Krystal Biotech made up 0.03% of Renaissance Technologies's portfolio in Q2 2026, its #657 holding.
  • Renaissance Technologies first reported a position in Krystal Biotech in Q3 2018 and has held it in 15 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.